PlainRecalls
FDA Drug Low Class III Terminated

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Reported: November 25, 2020 Initiated: November 11, 2020 #D-0100-2021

Product Description

Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.

Reason for Recall

Superpotent Drug: High out-of-specification assay results were obtained during stability testing.

Details

Recalling Firm
Teva Pharmaceuticals USA
Units Affected
12,088 cartons
Distribution
Product was distributed Nationwide in the USA.
Location
Parsippany, NJ

Frequently Asked Questions

What product was recalled?
Testosterone Gel 1%, 2.5 grams per unit dose, packaged in 2.5 gram Unit-Dose Packets (NDC 0591-3216-17); 30 Unit-Dose Packets per carton (NDC 0591-3216-30), Rx only, Manufactured by: Actavis Laboratories UT, Inc., Salt Lake City, UT 84108; Distributed by: Actavis Pharma, Inc., Parsippany, NJ 07054.. Recalled by Teva Pharmaceuticals USA. Units affected: 12,088 cartons.
Why was this product recalled?
Superpotent Drug: High out-of-specification assay results were obtained during stability testing.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 25, 2020. Severity: Low. Recall number: D-0100-2021.